Shilpa Medicare Limited (NSE:SHILPAMED)
707.95
-6.95 (-0.97%)
May 16, 2025, 3:30 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Active Pharmaceutical Ingredients | 7.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Active Pharmaceutical Ingredients Growth | 1.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Contract Development and Manufacturing Organization / License Fee | 2.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Contract Development and Manufacturing Organization / License Fee Growth | 159.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Formulations | 1.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Formulations Growth | -7.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 148.23M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -0.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Contract Research and Manufacturing Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Contract Research and Manufacturing Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Product and Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Product and Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Power | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Power Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
India | 5.39B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
India Growth | 5.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 2.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 10.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 2.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 40.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World | 1.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World Growth | -9.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|